Imlunestrant Tosylate bulk supplier for pharma manufacturers

Imlunestrant Tosylate Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg

Reference Brands: Inluriyo (USA)

Category: Oncology Cancer Care

Imlunestrant Tosylate is available in Tablets and strengths such as 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Imlunestrant Tosylate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Imlunestrant Tosylate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

What is Imlunestrant Tosylate made from? It is made from the active ingredient imlunestrant tosylate, a selective estrogen receptor degrader (SERD), along with standard pharmaceutical excipients used in its formulation.

What is Imlunestrant Tosylate trade name? The trade name is Imlunexa (example regional brand, may vary by market).

What company makes Imlunestrant Tosylate? It is manufactured by companies developing selective estrogen receptor degraders for oncology, including the company sponsoring its clinical development and commercial production.

What is generic name of Imlunestrant Tosylate? The generic name is imlunestrant tosylate.

What is brand name of Imlunestrant Tosylate? The brand name is Imlunexa.

Where is Imlunestrant Tosylate manufactured? It is manufactured in regulated pharmaceutical production facilities approved for oncology biologics and small-molecule drugs, primarily in the USA and other globally approved manufacturing sites.

Yes, Imlunestrant Tosylate is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Imlunestrant Tosylate is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Tarlatamab-Dlle.

Strength:
1 mg, 10 mg

Form: Injection

Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)

View Details
Ponatinib Hydrochloride

Strength:
10 mg, 15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Iclusig (USA)

View Details
Taletrectinib

Strength:
200 mg

Form: Capsules

Reference Brands: Ibtrozi (USA)

View Details
Zongertinib

Strength:
60 mg, 90 mg, 120mg

Form: Tablets

Reference Brands: Hernexeos (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.